Suzano S.A.'s SEC filings document its status as a Brazilian foreign private issuer with American depositary shares listed on the NYSE and ordinary shares traded on B3. Annual Form 20-F reporting and Form 6-K current reports cover consolidated pulp, paper and packaging results, IFRS financial statements, operating metrics, debt, leverage, cash generation and risk disclosures for an integrated forestry-based producer.
The filing record also includes bylaws, board and shareholder meeting minutes, dividend notices, financing disclosures involving rural product notes and debentures, and governance materials tied to the company's authorized-capital structure and Novo Mercado listing obligations. These documents provide formal disclosure on capital structure, shareholder approvals, corporate governance and material operating updates.
Suzano S.A. delivered a sharp turnaround for the nine months ended September 30, 2025, posting net income of R$13.3 billion after a loss in the prior-year period. Net sales reached R$37.0 billion, up from R$33.2 billion, while operating profit before net financial items was R$7.1 billion.
Strong derivative and foreign-exchange results drove a large positive net financial result, supporting earnings. Operating cash flow was solid at R$12.8 billion, lifting cash and cash equivalents to R$15.8 billion. Total shareholders’ equity rose to R$45.3 billion, with total assets of R$164.4 billion and loans, financing and debentures of R$93.0 billion.
The company also agreed to acquire a 51% stake in a global tissue business carved out of Kimberly-Clark for US$1,734 billion (about R$9,222 billions), adding 22 production facilities in 14 countries. Closing is subject to regulatory and other conditions and is expected by mid-2026, with no accounting impact yet recognized.